It should also be mentioned that RA-ILD+ patients presented the lowest PRMT1 expression, probably as a result of post-transcriptional regulatory mechanisms (Greenbaum et al., 2003; Stevens and Brown, 2013; Li et al., 2020). Here, PRMT1 is linked to interstitial lung disease.